It's looking like inflammation is a major contributing factor in many, many diseases and that's why STSI looks so promising. Here is something weird: my brother has Krohn's disease and medical professionals have actually told him that his smoking probably lessens it. When I told my doctor that (who is a customer of Anatabloc and a STSI shareholder) he told me he's seen cases where people quit smoking and suddenly their Krohn's flares up. Sounds like Anatabloc could help those people so they could quit smoking.
Market Data 
Markets 
AI
